In addition to ubiquitination, HERC2 contains an intronic regulatory element known to inhibit the promoter of OCA2. Deletion of OCA2 is also associated with PWS, Angelman syndrome, and Oculocutaneous Albinism type 2. Here, OCA2 is linked to Angelman syndrome.